Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
Diabetes Mellitus, Insulin-Dependent
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Insulin-Dependent focused on measuring type 1 diabetes, diabetes, new onset, CSII, insulin sensitivity, beta cell function, beta cell preservation
Eligibility Criteria
Inclusion Criteria: Male or female patient between the age of 12 and 17 years inclusive at time of entry into study (i.e., after their 12th but before their 18th birthday) Type 1 diabetes mellitus for no more than 10 days pubertal (Tanner stage 2 or above) The patient and parents or guardians should be able to do simple math calculations (necessary for pump management) Parent or legal guardian must give signed informed consent Exclusion Criteria: No other chronic medical conditions (well-controlled thyroid disease is OK, and mild asthma is OK if the patient is not on chronic inhaled or oral daily corticosteroids) Exceptional psychological stress, more than expected for circumstances of having the new diagnosis of diabetes Inability or unwillingness to comply with requirements of the protocol
Sites / Locations
- Nemours Children's Clinic
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Pump therapy (CSII)
Multiple daily injections (MDI)
Use of pump therapy
Use of MDI (basal bolus therapy with glargine)